Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Acosta

Showing results (61-70 of 338) with videos related to

Pageof 34
Sort By:
HIV Clinical Trials|October 9, 2001
Combination therapy with indinavir, ritonavir, and delavirdine and nucleoside reverse transcriptase inhibitors in patients with HIV/AIDS who have failed multiple antiretroviral combinationsM Grodesky, E P Acosta, N Fujita, et al.
Pharmacotherapy|March 7, 2012
Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infectionUriel Sandkovsky, Susan Swindells, Ryan Moore, et al.
Biotechnology and Bioengineering|August 3, 2010
Ultra scale-down stress analysis of the bioprocessing of whole human cells as a basis for cancer vaccinesJ P Acosta-Martinez, I Papantoniou, K Lawrence, et al.
The Journal of Infectious Diseases|July 19, 2012
Oseltamivir dosing in premature infantsChristopher McPherson, Barbara Warner, David A Hunstad, et al.
HIV Clinical Trials|November 25, 2004
Pharmacokinetics of antiretrovirals administered to HIV-infected children via gastrostomy tubeJennifer R King, Ram Yogev, Grace Aldrovandi, et al.
Clinical Pharmacokinetics|August 29, 2014
Pharmacokinetic enhancers in HIV therapeuticsKajal B Larson, Kun Wang, Cecile Delille, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Helicase-primase as a target of new therapies for herpes simplex virus infectionsS H James, K B Larson, E P Acosta, et al.
Journal of Animal Science and Biotechnology|May 15, 2025
Growth performance and total tract digestibility of nutrients for weanling pigs are improved by an exogenous xylanase and a stimbiotic regardless of maternal xylanase consumptionJessica P Acosta, Charmaine D Espinosa, Gemma González-Ortiz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Antiretroviral drug content in products from developing countriesScott R Penzak, Edward P Acosta, Michele Turner, et al.
Pharmacotherapy|December 25, 2007
Pharmacokinetics of an indinavir-ritonavir-fosamprenavir regimen in patients with human immunodeficiency virusIghovwerha Ofotokun, Edward P Acosta, Jeffrey L Lennox, et al.
Pageof 34

Showing results (61-70 of 338) with videos related to

Sort By:
Pageof 34
HIV Clinical Trials|October 9, 2001
Combination therapy with indinavir, ritonavir, and delavirdine and nucleoside reverse transcriptase inhibitors in patients with HIV/AIDS who have failed multiple antiretroviral combinationsM Grodesky, E P Acosta, N Fujita, et al.
Pharmacotherapy|March 7, 2012
Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infectionUriel Sandkovsky, Susan Swindells, Ryan Moore, et al.
Biotechnology and Bioengineering|August 3, 2010
Ultra scale-down stress analysis of the bioprocessing of whole human cells as a basis for cancer vaccinesJ P Acosta-Martinez, I Papantoniou, K Lawrence, et al.
The Journal of Infectious Diseases|July 19, 2012
Oseltamivir dosing in premature infantsChristopher McPherson, Barbara Warner, David A Hunstad, et al.
HIV Clinical Trials|November 25, 2004
Pharmacokinetics of antiretrovirals administered to HIV-infected children via gastrostomy tubeJennifer R King, Ram Yogev, Grace Aldrovandi, et al.
Clinical Pharmacokinetics|August 29, 2014
Pharmacokinetic enhancers in HIV therapeuticsKajal B Larson, Kun Wang, Cecile Delille, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Helicase-primase as a target of new therapies for herpes simplex virus infectionsS H James, K B Larson, E P Acosta, et al.
Journal of Animal Science and Biotechnology|May 15, 2025
Growth performance and total tract digestibility of nutrients for weanling pigs are improved by an exogenous xylanase and a stimbiotic regardless of maternal xylanase consumptionJessica P Acosta, Charmaine D Espinosa, Gemma González-Ortiz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Antiretroviral drug content in products from developing countriesScott R Penzak, Edward P Acosta, Michele Turner, et al.
Pharmacotherapy|December 25, 2007
Pharmacokinetics of an indinavir-ritonavir-fosamprenavir regimen in patients with human immunodeficiency virusIghovwerha Ofotokun, Edward P Acosta, Jeffrey L Lennox, et al.
Pageof 34